Labcorp Holdings Inc. closed 4.84% short of its 52-week high of $293.72, which the company reached on October 21st.

The leader of the Triad’s second-largest public company and only member of the Fortune 500, Schechter has led Labcorp to ...

Europe: Labcorp recently took a stake in SYNLAB, a big European lab company. This could be a way to test the waters and see ...

Labcorp plans to offer Roche’s recently FDA-cleared blood test to assess early signs of Alzheimer’s disease and other causes ...

A merger would significantly change the competitive scene. With Quest and Labcorp being major players, their combination ...

Labcorp announced it will offer the nation's first blood test cleared by the FDA for the initial assessment in Alzheimer's ...

The Burlington, N.C., lab-services company on Thursday said the Elecsys pTau181 test, developed by Swiss drugmaker Roche Holding and approved for commercialization by the U.S. Food and Drug ...

Labcorp announced it will begin offering the Elecsys pTau181 blood test nationwide by early 2026, making available the only FDA-cleared blood test in the U.S. to aid in the initial assessment for ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer the Elecsys pTau181 test, the only blood test cleared by the U.S. Food and Drug ...

Quest Diagnostics Incorporated shows post-pandemic growth with Q3 results, strategic expansion, and steady returns. Click for ...

Praia Health’s latest announcements aim to boost patient engagement across health systems by streamlining data and operations ...

Labcorp Holdings Inc. advanced stock charts by Barron's. View LH historical stock data and compare to other stocks, and exchanges.